(BUR) Burford Capital - Overview
Exchange: NYSE •
Country: Guernsey •
Currency: USD •
Type: Common Stock •
ISIN: GG00BMGYLN96
Stock: Litigation Finance, Legal Cost Insurance, Asset Management, Risk Management
Total Rating 15
Risk 34
Buy Signal -1.54
Dividends
| Dividend Yield | 1.11% |
| Yield on Cost 5y | 1.56% |
| Yield CAGR 5y | -9.70% |
| Payout Consistency | 79.7% |
| Payout Ratio | 28.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 43.0% |
| Relative Tail Risk | -7.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.88 |
| Alpha | -53.60 |
| Character TTM | |
|---|---|
| Beta | 1.122 |
| Beta Downside | 1.123 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.34% |
| CAGR/Max DD | 0.08 |
Description: BUR Burford Capital January 11, 2026
Burford Capital Ltd (NYSE: BUR) is a Guernsey-incorporated provider of legal finance products, offering capital to law firms and litigants on a contingent-fee or alternative-fee basis, as well as legal risk-management and adverse-cost insurance services.
The firm operates two core segments: (1) **Principal Finance**, which funds high-value litigation and arbitration matters at any stage-from pre-filing to post-judgment-and (2) **Asset Management and Other Services**, which manages legal-finance assets for third-party investors and delivers ancillary services to the legal industry.
Key performance indicators (as of FY 2024) include ≈ $2.3 billion of total assets under management, a net income of $68 million, and a return on invested capital (ROIC) of roughly 9%. The sector’s growth is driven by increasing litigation funding demand in the U.S. and Europe, a low-interest-rate environment that lowers the cost of capital, and the rise of “third-party funding” as a hedge against legal cost volatility.
For a deeper, data-rich view of Burford’s valuation dynamics, you may find ValueRay’s analytical dashboards worth a look.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 86.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.39 > 1.0 |
| NWC/Revenue: 200.6% < 20% (prev 106.6%; Δ 93.98% < -1%) |
| CFO/TA 0.03 > 3% & CFO 206.1m > Net Income 86.0m |
| Net Debt (-677.7m) to EBITDA (153.9m): -4.40 < 3 |
| Current Ratio: 62.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (219.3m) vs 12m ago -1.92% < -2% |
| Gross Margin: 70.73% > 18% (prev 0.78%; Δ 6995 % > 0.5%) |
| Asset Turnover: 5.73% > 50% (prev 8.93%; Δ -3.20% > 0%) |
| Interest Coverage Ratio: 0.17 > 6 (EBITDA TTM 153.9m / Interest Expense TTM 137.7m) |
Altman Z'' 2.39
| A: 0.11 (Total Current Assets 756.7m - Total Current Liabilities 12.1m) / Total Assets 6.69b |
| B: 0.28 (Retained Earnings 1.85b / Total Assets 6.69b) |
| C: 0.00 (EBIT TTM 23.8m / Avg Total Assets 6.48b) |
| D: 0.70 (Book Value of Equity 2.44b / Total Liabilities 3.50b) |
| Altman-Z'' Score: 2.39 = BBB |
Beneish M -0.16
| DSRI: 4.70 (Receivables 201.0m/64.5m, Revenue 371.2m/560.2m) |
| GMI: 1.10 (GM 70.73% / 77.83%) |
| AQI: 0.99 (AQ_t 0.88 / AQ_t-1 0.90) |
| SGI: 0.66 (Revenue 371.2m / 560.2m) |
| TATA: -0.02 (NI 86.0m - CFO 206.1m) / TA 6.69b) |
| Beneish M-Score: -0.16 (Cap -4..+1) = D |
What is the price of BUR shares?
As of February 07, 2026, the stock is trading at USD 8.92 with a total of 2,155,412 shares traded.
Over the past week, the price has changed by -7.95%, over one month by -3.98%, over three months by -1.55% and over the past year by -37.48%.
Over the past week, the price has changed by -7.95%, over one month by -3.98%, over three months by -1.55% and over the past year by -37.48%.
Is BUR a buy, sell or hold?
Burford Capital has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy BUR.
- StrongBuy: 5
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BUR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.1 | 114.5% |
| Analysts Target Price | 19.1 | 114.5% |
| ValueRay Target Price | 8.6 | -3.3% |
BUR Fundamental Data Overview February 03, 2026
P/E Trailing = 24.225
P/E Forward = 9.6805
P/S = 4.5503
P/B = 0.8468
Revenue TTM = 371.2m USD
EBIT TTM = 23.8m USD
EBITDA TTM = 153.9m USD
Long Term Debt = unknown (none)
Short Term Debt = 3.16m USD (from shortTermDebt, last fiscal year)
Debt = 1.78b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -677.7m USD (from netDebt column, last quarter)
Enterprise Value = 3.14b USD (2.12b + Debt 1.78b - CCE 756.7m)
Interest Coverage Ratio = 0.17 (Ebit TTM 23.8m / Interest Expense TTM 137.7m)
EV/FCF = 15.27x (Enterprise Value 3.14b / FCF TTM 205.8m)
FCF Yield = 6.55% (FCF TTM 205.8m / Enterprise Value 3.14b)
FCF Margin = 55.45% (FCF TTM 205.8m / Revenue TTM 371.2m)
Net Margin = 23.16% (Net Income TTM 86.0m / Revenue TTM 371.2m)
Gross Margin = 70.73% ((Revenue TTM 371.2m - Cost of Revenue TTM 108.7m) / Revenue TTM)
Gross Margin QoQ = 83.93% (prev 80.57%)
Tobins Q-Ratio = 0.47 (Enterprise Value 3.14b / Total Assets 6.69b)
Interest Expense / Debt = 2.26% (Interest Expense 40.2m / Debt 1.78b)
Taxrate = 9.47% (24.0m / 253.6m)
NOPAT = 21.5m (EBIT 23.8m * (1 - 9.47%))
Current Ratio = 62.56 (Total Current Assets 756.7m / Total Current Liabilities 12.1m)
Debt / Equity = 0.71 (Debt 1.78b / totalStockholderEquity, last quarter 2.50b)
Debt / EBITDA = -4.40 (Net Debt -677.7m / EBITDA 153.9m)
Debt / FCF = -3.29 (Net Debt -677.7m / FCF TTM 205.8m)
Total Stockholder Equity = 2.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.33% (Net Income 86.0m / Total Assets 6.69b)
RoE = 3.49% (Net Income TTM 86.0m / Total Stockholder Equity 2.46b)
RoCE = 0.36% (EBIT 23.8m / Capital Employed (Total Assets 6.69b - Current Liab 12.1m))
RoIC = 0.50% (NOPAT 21.5m / Invested Capital 4.33b)
WACC = 6.40% (E(2.12b)/V(3.90b) * Re(10.05%) + D(1.78b)/V(3.90b) * Rd(2.26%) * (1-Tc(0.09)))
Discount Rate = 10.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.08%
[DCF Debug] Terminal Value 78.11% ; FCFF base≈210.5m ; Y1≈138.2m ; Y5≈63.0m
Fair Price DCF = 11.05 (EV 1.74b - Net Debt -677.7m = Equity 2.42b / Shares 218.9m; r=6.40% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -3.94 | EPS CAGR: 0.0% | SUE: -1.04 | # QB: 0
Revenue Correlation: 25.40 | Revenue CAGR: -14.88% | SUE: -0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.34 | Chg30d=+0.053 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.59 | Chg30d=+0.212 | Revisions Net=+1 | Growth EPS=+44.0% | Growth Revenue=+30.6%
P/E Forward = 9.6805
P/S = 4.5503
P/B = 0.8468
Revenue TTM = 371.2m USD
EBIT TTM = 23.8m USD
EBITDA TTM = 153.9m USD
Long Term Debt = unknown (none)
Short Term Debt = 3.16m USD (from shortTermDebt, last fiscal year)
Debt = 1.78b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -677.7m USD (from netDebt column, last quarter)
Enterprise Value = 3.14b USD (2.12b + Debt 1.78b - CCE 756.7m)
Interest Coverage Ratio = 0.17 (Ebit TTM 23.8m / Interest Expense TTM 137.7m)
EV/FCF = 15.27x (Enterprise Value 3.14b / FCF TTM 205.8m)
FCF Yield = 6.55% (FCF TTM 205.8m / Enterprise Value 3.14b)
FCF Margin = 55.45% (FCF TTM 205.8m / Revenue TTM 371.2m)
Net Margin = 23.16% (Net Income TTM 86.0m / Revenue TTM 371.2m)
Gross Margin = 70.73% ((Revenue TTM 371.2m - Cost of Revenue TTM 108.7m) / Revenue TTM)
Gross Margin QoQ = 83.93% (prev 80.57%)
Tobins Q-Ratio = 0.47 (Enterprise Value 3.14b / Total Assets 6.69b)
Interest Expense / Debt = 2.26% (Interest Expense 40.2m / Debt 1.78b)
Taxrate = 9.47% (24.0m / 253.6m)
NOPAT = 21.5m (EBIT 23.8m * (1 - 9.47%))
Current Ratio = 62.56 (Total Current Assets 756.7m / Total Current Liabilities 12.1m)
Debt / Equity = 0.71 (Debt 1.78b / totalStockholderEquity, last quarter 2.50b)
Debt / EBITDA = -4.40 (Net Debt -677.7m / EBITDA 153.9m)
Debt / FCF = -3.29 (Net Debt -677.7m / FCF TTM 205.8m)
Total Stockholder Equity = 2.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.33% (Net Income 86.0m / Total Assets 6.69b)
RoE = 3.49% (Net Income TTM 86.0m / Total Stockholder Equity 2.46b)
RoCE = 0.36% (EBIT 23.8m / Capital Employed (Total Assets 6.69b - Current Liab 12.1m))
RoIC = 0.50% (NOPAT 21.5m / Invested Capital 4.33b)
WACC = 6.40% (E(2.12b)/V(3.90b) * Re(10.05%) + D(1.78b)/V(3.90b) * Rd(2.26%) * (1-Tc(0.09)))
Discount Rate = 10.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.08%
[DCF Debug] Terminal Value 78.11% ; FCFF base≈210.5m ; Y1≈138.2m ; Y5≈63.0m
Fair Price DCF = 11.05 (EV 1.74b - Net Debt -677.7m = Equity 2.42b / Shares 218.9m; r=6.40% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -3.94 | EPS CAGR: 0.0% | SUE: -1.04 | # QB: 0
Revenue Correlation: 25.40 | Revenue CAGR: -14.88% | SUE: -0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.34 | Chg30d=+0.053 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.59 | Chg30d=+0.212 | Revisions Net=+1 | Growth EPS=+44.0% | Growth Revenue=+30.6%